What companies are EPRX's competitors?

Eupraxia Pharmaceuticals Inc. (EPRX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does EPRX compare to its peers?

The peer comparison table on this page shows Eupraxia Pharmaceuticals Inc. (EPRX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does EPRX operate in?

Eupraxia Pharmaceuticals Inc. (EPRX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

EPRX

Eupraxia Pharmaceuticals Inc.

NASDAQ·Biotechnology · Healthcare

$7.43$0.01+0.13%

After hours·$7.52+1.24%

Market cap$248.76M·Market closed·Aug 26 8:00 PM UTC

Frequently Asked Questions About EPRX

What companies are EPRX's competitors?: Eupraxia Pharmaceuticals Inc. (EPRX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does EPRX compare to its peers?: The peer comparison table on this page shows Eupraxia Pharmaceuticals Inc. (EPRX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does EPRX operate in?: Eupraxia Pharmaceuticals Inc. (EPRX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

EPRX

Eupraxia Pharmaceuticals Inc.

NASDAQ·Biotechnology · Healthcare

$7.43$0.01+0.13%

After hours·$7.52+1.24%

Market cap$248.76M·Market closed·Aug 26 8:00 PM UTC

Peers


SLS	SELLAS Life Sciences Group, Inc.	$13.73	$2.6B
GNFT	Genfit S.A.	$8.95	$445.7M
OBIO	Orchestra BioMed Holdings, Inc.	$5.26	$315.0M
RNAC	Cartesian Therapeutics, Inc.	$10.19	$299.4M
IVA	Inventiva S.A.	€4.82	€250.6M
TARA	Protara Therapeutics, Inc.	$3.91	$219.8M
MDWD	MediWound Ltd.	$12.70	$163.1M
AARD	Aardvark Therapeutics, Inc. Common Stock	$6.81	$149.0M
NTHI	Neonc Technologies Holdings, Inc.	$4.56	$118.2M
NAUT	Nautilus Biotechnolgy, Inc.	$0.88	$112.2M

Frequently Asked Questions About EPRX

What companies are EPRX's competitors?: Eupraxia Pharmaceuticals Inc. (EPRX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does EPRX compare to its peers?: The peer comparison table on this page shows Eupraxia Pharmaceuticals Inc. (EPRX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does EPRX operate in?: Eupraxia Pharmaceuticals Inc. (EPRX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.